Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Madlaina Breuleux

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Current Opinion in Cell Biology|February 24, 2009
Optimal targeting of the mTORC1 kinase in human cancerHeidi A Lane, Madlaina Breuleux
Journal of Virology|May 9, 2008
Recombinant adeno-associated viral vectors are deficient in provoking a DNA damage responseMichalis Fragkos, Madlaina Breuleux, Nathalie Clément, et al.
Molecular Cancer Research : MCR|February 1, 2006
Heregulins implicated in cellular functions other than receptor activationMadlaina Breuleux, Fabrice Schoumacher, Daniel Rehn, et al.
Molecular Cancer Therapeutics|April 18, 2009
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibitionMadlaina Breuleux, Matthieu Klopfenstein, Christine Stephan, et al.
Cancer Research|May 17, 2008
The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancerAnne Boulay, Madlaina Breuleux, Christine Stephan, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Current Opinion in Cell Biology|February 24, 2009
Optimal targeting of the mTORC1 kinase in human cancerHeidi A Lane, Madlaina Breuleux
Journal of Virology|May 9, 2008
Recombinant adeno-associated viral vectors are deficient in provoking a DNA damage responseMichalis Fragkos, Madlaina Breuleux, Nathalie Clément, et al.
Molecular Cancer Research : MCR|February 1, 2006
Heregulins implicated in cellular functions other than receptor activationMadlaina Breuleux, Fabrice Schoumacher, Daniel Rehn, et al.
Molecular Cancer Therapeutics|April 18, 2009
Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibitionMadlaina Breuleux, Matthieu Klopfenstein, Christine Stephan, et al.
Cancer Research|May 17, 2008
The Ret receptor tyrosine kinase pathway functionally interacts with the ERalpha pathway in breast cancerAnne Boulay, Madlaina Breuleux, Christine Stephan, et al.
Pageof 1